Efficacy of once daily tobramycin for acute pulmonary exacerbations of cystic fibrosis (CF) - A microbiological perspective

被引:0
|
作者
Al-Ansari, N
McKeon, D
Parmar, J
Gunn, E
Foweraker, J
Bilton, D
机构
[1] Papworth Hosp, Dept Microbiol, Cambridge CB3 8RE, England
[2] Papworth Hosp, Adult Cyst Fibrosis Ctr, Cambridge CB3 8RE, England
关键词
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
P135
引用
收藏
页码:84 / 85
页数:2
相关论文
共 50 条
  • [1] Efficacy of once-daily tobramycin monotherapy for acute pulmonary exacerbations of cystic fibrosis: A preliminary study
    Master, V
    Roberts, GW
    Coulthard, KP
    Baghurst, PA
    Martin, A
    Roberts, ME
    Onishko, CR
    Martin, AJ
    Linke, RJ
    Holmes, M
    Jarvinen, A
    Kennedy, D
    Colebatch, KA
    Hansman, D
    Parsons, DW
    PEDIATRIC PULMONOLOGY, 2001, 31 (05) : 367 - 376
  • [2] Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis
    Vic, P
    Ategbo, S
    Turck, D
    Husson, MO
    Launay, V
    Loeuille, GA
    Sardet, A
    Deschildre, A
    Druon, D
    Arrouet-Lagande, C
    ARCHIVES OF DISEASE IN CHILDHOOD, 1998, 78 (06) : 536 - 539
  • [3] Evaluation of an empiric once daily tobramycin dosing regimen for pulmonary exacerbations in children and adults with cystic fibrosis
    VandenBussche, H. L.
    Marks, J. H.
    Homnick, D. N.
    PEDIATRIC PULMONOLOGY, 2007, : 321 - 321
  • [4] Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis - Dr Vic and colleagues comment
    Vic, P
    Ategbo, S
    Turck, D
    ARCHIVES OF DISEASE IN CHILDHOOD, 1999, 80 (02) : 207 - 208
  • [5] The efficacy and safety of meropenem and tobramycin vs ceftazidime and tobramycin in the treatment of acute pulmonary exacerbations in patients with cystic fibrosis
    Blumer, JL
    Saiman, L
    Konstan, MW
    Melnick, D
    CHEST, 2005, 128 (04) : 2336 - 2346
  • [6] ASSESSMENT OF TOBRAMYCIN DOSING IN CYSTIC FIBROSIS PATIENTS WITH ACUTE PULMONARY EXACERBATIONS
    Thirion, D. J.
    Koloskoff, K.
    Caissy, J.
    Matouk, E.
    Marsot, A.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S177 - S178
  • [7] EFFICACY OF INHALED TOBRAMYCIN IN THE TREATMENT OF PULMONARY EXACERBATIONS IN CHILDREN WITH CYSTIC-FIBROSIS
    STEPHENS, D
    GAREY, N
    ISLES, A
    LEVISON, H
    GOLD, R
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1983, 2 (03) : 209 - 211
  • [8] EFFICACY AND SAFETY OF COLISTIN COMPARED TO TOBRAMYCIN FOR INTRAVENOUS TREATMENT OF ACUTE PULMONARY EXACERBATIONS IN ADULTS WITH CYSTIC FIBROSIS
    Saavedra, M. T.
    Poch, K.
    Casciano, M.
    Kiser, T.
    Fish, D.
    Kuk, K.
    Nichols, D.
    Taylor-Cousar, J. L.
    Strand, M.
    Nick, J. A.
    PEDIATRIC PULMONOLOGY, 2015, 50 : 355 - 355
  • [9] Efficacy And Safety Of Colistin Compared To Tobramycin For Intravenous Treatment Of Acute Pulmonary Exacerbations In Adults With Cystic Fibrosis
    Saavedra, M.
    Poch, K. R.
    Casciano, M.
    Kiser, T. H.
    Fish, D.
    Morris, A.
    Nichols, D. P.
    Taylor-Cousar, J. L.
    Strand, M.
    Nick, J. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [10] Tolerance, pharmacokinetics and efficacy of once daily amikacin for treatment of Pseudomonas aeruginosa pulmonary exacerbations In cystic fibrosis patients
    Vic, P
    Ategbo, S
    Turck, D
    Husson, MO
    Tassin, E
    Loeuille, GA
    Deschildre, A
    Druon, D
    Elian, JC
    ArrouetLagandre, C
    Farriaux, JP
    EUROPEAN JOURNAL OF PEDIATRICS, 1996, 155 (11) : 948 - 953